Alternate day fasting for weight loss in normal weight and overweight subjects: a randomized controlled trial - PubMed (original) (raw)

Randomized Controlled Trial

Alternate day fasting for weight loss in normal weight and overweight subjects: a randomized controlled trial

Krista A Varady et al. Nutr J. 2013.

Abstract

Background: Alternate day fasting (ADF; ad libitum "feed day", alternated with 25% energy intake "fast day"), is effective for weight loss and cardio-protection in obese individuals. Whether these effects occur in normal weight and overweight individuals remains unknown. This study examined the effect of ADF on body weight and coronary heart disease risk in non-obese subjects.

Methods: Thirty-two subjects (BMI 20-29.9 kg/m2) were randomized to either an ADF group or a control group for 12 weeks.

Results: Body weight decreased (P < 0.001) by 5.2 ± 0.9 kg (6.5 ± 1.0%) in the ADF group, relative to the control group, by week 12. Fat mass was reduced (P < 0.001) by 3.6 ± 0.7 kg, and fat free mass did not change, versus controls. Triacylglycerol concentrations decreased (20 ± 8%, P < 0.05) and LDL particle size increased (4 ± 1 Å, P < 0.01) in the ADF group relative to controls. CRP decreased (13 ± 17%, P < 0.05) in the ADF group relative to controls at week 12. Plasma adiponectin increased (6 ± 10%, P < 0.01) while leptin decreased (40 ± 7%, P < 0.05) in the ADF group versus controls by the end of the study. LDL cholesterol, HDL cholesterol, homocysteine and resistin concentrations remained unchanged after 12 weeks of treatment.

Conclusion: These findings suggest that ADF is effective for weight loss and cardio-protection in normal weight and overweight adults, though further research implementing larger sample sizes is required before solid conclusion can be reached.

PubMed Disclaimer

Figures

Figure 1

Figure 1

Study flow chart. ADF: Alternate day fasting.

Figure 2

Figure 2

Body weight and body composition changes at week 12. Values reported as mean ± SEM. ADF: Alternate day fasting. *Body weight and fat mass significantly different (P < 0.001) from the control group at week 12 (Independent samples _t_-test). No difference between groups for fat free mass at week 12 (Independent samples _t_-test).

Similar articles

Cited by

References

    1. Varady KA, Hellerstein MK. Alternate-day fasting and chronic disease prevention: a review of human and animal trials. Am J Clin Nutr. 2007;86:7–13. - PubMed
    1. Varady KA, Bhutani S, Church EC, Klempel MC. Short-term modified alternate-day fasting: a novel dietary strategy for weight loss and cardioprotection in obese adults. Am J Clin Nutr. 2009;90:1138–1143. doi: 10.3945/ajcn.2009.28380. - DOI - PubMed
    1. Klempel MC, Kroeger CM, Varady KA. Alternate day fasting (ADF) with a high-fat diet produces similar weight loss and cardio-protection as ADF with a low-fat diet. Metabolism. 2013;62:137–143. doi: 10.1016/j.metabol.2012.07.002. - DOI - PubMed
    1. Bhutani S, Klempel MC, Kroeger CM, Trepanowski JF, Varady KA. Alternate day fasting and endurance exercise combine to reduce body weight and favorably alter plasma lipids in obese humans. Obesity (Silver Spring) 2013. Epub ahead of print. - PubMed
    1. Heilbronn LK, Smith SR, Martin CK, Anton SD, Ravussin E. Alternate-day fasting in nonobese subjects: effects on body weight, body composition, and energy metabolism. Am J Clin Nutr. 2005;81:69–73. - PubMed

Publication types

MeSH terms

Substances

LinkOut - more resources